Literature DB >> 31368412

Active Surveillance for Small Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis.

Se Jin Cho1, Chong Hyun Suh1, Jung Hwan Baek1, Sae Rom Chung1, Young Jun Choi1, Ki-Wook Chung2, Young Kee Shong3, Jeong Hyun Lee1.   

Abstract

Background: The rapid increase in the incidence of small papillary thyroid carcinoma (PTC) appears to be caused by the detection of small thyroid cancers. Active surveillance (AS) was therefore suggested to overcome this problem. As the results were favorable with low rates of size enlargement and lymph metastasis, the 2015 American Thyroid Association Management Guidelines endorsed AS as an alternative to immediate surgery. As the clinical value of AS is a subject of ongoing active discussions and surveys, we considered a systematic review and meta-analysis to be timely and necessary.
Methods: Ovid-MEDLINE and EMBASE databases were searched up to January 5, 2019, for studies reporting patients who were followed up with AS for PTC. Data extraction and methodological quality assessment were performed independently by two radiologists. The primary outcomes were to identify the annual pooled proportions of size enlargement of 3 mm or more and the detection of lymph node metastases at a 5-year follow-up period. These were calculated using an inverse-variance weighting model. An additional outcome was evaluation of the reasons for surgery during AS.
Results: The pooled proportion of size enlargement occurring at 5 years was 5.3% [95% confidence interval (CI), 4.4-6.4%], and the pooled proportion of 5-year lymph node metastasis was 1.6% [CI, 1.1-2.4%]. In many subjects undergoing delayed operations, the reasons for operation were often other than those of size enlargement or lymph node metastasis. Conclusions: AS is effective for the management of small PTC, with a low proportion of size enlargement or lymph node metastasis occurring at 5 years. However, a substantial proportion of the causes of delayed surgery were other than size enlargement or lymph node metastasis, and these situations need to be optimally managed.

Entities:  

Keywords:  active surveillance; papillary thyroid cancer; systematic review and meta-analysis

Year:  2019        PMID: 31368412     DOI: 10.1089/thy.2019.0159

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  25 in total

1.  Five-year follow-up results of thermal ablation for low-risk papillary thyroid microcarcinomas: systematic review and meta-analysis.

Authors:  Se Jin Cho; Sun Mi Baek; Dong Gyu Na; Kang Dae Lee; Young Kee Shong; Jung Hwan Baek
Journal:  Eur Radiol       Date:  2021-03-13       Impact factor: 5.315

Review 2.  Overview of the 2022 WHO Classification of Thyroid Neoplasms.

Authors:  Zubair W Baloch; Sylvia L Asa; Justine A Barletta; Ronald A Ghossein; C Christofer Juhlin; Chan Kwon Jung; Virginia A LiVolsi; Mauro G Papotti; Manuel Sobrinho-Simões; Giovanni Tallini; Ozgur Mete
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 3.943

3.  Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma.

Authors:  Lin Yan; Xinyang Li; Yingying Li; Jing Xiao; Mingbo Zhang; Yukun Luo
Journal:  Eur Radiol       Date:  2022-07-27       Impact factor: 7.034

4.  Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.

Authors:  Y Feng; Y Min; H Chen; K Xiang; X Wang; G Yin
Journal:  J Endocrinol Invest       Date:  2021-02-14       Impact factor: 4.256

5.  Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey.

Authors:  Susan C Pitt; Nan Yang; Megan C Saucke; Nicholas Marka; Bret Hanlon; Kristin L Long; Alexandria D McDow; J P Brito; Benjamin R Roman
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

6.  A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer.

Authors:  Anna M Sawka; Sangeet Ghai; George Tomlinson; Nancy N Baxter; Martin Corsten; Syed Ali Imran; Eric Bissada; Rebecca Lebouef; Nathalie Audet; Maryse Brassard; Han Zhang; Michael Gupta; Anthony C Nichols; Deric Morrison; Stephanie Johnson-Obeski; Eitan Prisman; Don Anderson; Shamir P Chandarana; Sana Ghaznavi; Jennifer Jones; Amiram Gafni; John J Matelski; Wei Xu; David P Goldstein
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

7.  Barriers to the Use of Active Surveillance for Thyroid Cancer Results of a Physician Survey.

Authors:  David T Hughes; David Reyes-Gastelum; Kevin C Ward; Ann S Hamilton; Megan R Haymart
Journal:  Ann Surg       Date:  2020-10-16       Impact factor: 13.787

Review 8.  Contemporary Thyroid Nodule Evaluation and Management.

Authors:  Giorgio Grani; Marialuisa Sponziello; Valeria Pecce; Valeria Ramundo; Cosimo Durante
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

9.  Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study.

Authors:  Lin Yan; Mingbo Zhang; Qing Song; Fang Xie; Yukun Luo
Journal:  Eur Radiol       Date:  2021-08-06       Impact factor: 5.315

10.  Proceedings of the Canadian Thyroid Cancer Active Surveillance Study Group 2019 national investigator meeting.

Authors:  David P Goldstein; Sangeet Ghai; Martin Corsten; Eric Bissada; Nathalie Audet; Han Zhang; Anthony Nichols; Deric Morrison; Stephanie Johnson-Obeski; Donald W Anderson; Eitan Prisman; Nancy N Baxter; Jennifer Jones; Amiram Gafni; Ian Witterick; Anna M Sawka
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.